In contrast, TGF‐β functionally switches to a pro‐tumorigenic signal when the tumor advances toward malignancy, instigating aggressive tumor characteristics such as cancer cells' immune evasion, alteration of the tumor microenvironment, and epithelial‐mesenchymal transition. Here, TGFB1 is linked to neoplasm.